Mirum Pharmaceuticals (MIRM) Other Non Operating Income (2019 - 2026)

Mirum Pharmaceuticals' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$218000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 77.8% year-over-year to -$218000.0; the TTM figure through Mar 2026 stood at $263000.0 (down 25.07% YoY), while the FY2025 annual figure was $2.4 million, changed N/A from the prior year.
• Other Non Operating Income for Q4 2025 stood at -$218000.0, down from $395000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $46.3 million in Q4 2023, with the low at -$49.1 million in Q2 2023.
• The 5-year median for Other Non Operating Income is -$17000.0 (2021), against an average of -$96176.5.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income slumped 862.5% in 2022, then jumped 12571.78% in 2023.
• Mirum Pharmaceuticals' Other Non Operating Income stood at -$17000.0 in 2021, then soared by 2247.06% to $365000.0 in 2022, then surged by 12571.78% to $46.3 million in 2023, then slumped by 102.12% to -$982000.0 in 2024, then jumped by 77.8% to -$218000.0 in 2025.
• Business Quant data shows MIRM's Other Non Operating Income at -$218000.0 in Q4 2025, $395000.0 in Q3 2025, and $86000.0 in Q2 2025.